Dr. Do-Youn Oh, MD
Claim this profileSeoul National University Hospital
Studies Cancer
Studies Stomach Cancer
26 reported clinical trials
50 drugs studied
Area of expertise
1Cancer
HER2 positive
Stage IV
Stage III
2Stomach Cancer
Stage IV
Stage III
HER2 positive
Clinical Trials Do-Youn Oh, MD is currently running
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting2 awards Phase 3
CYC140
for Advanced Cancers and Lymphoma
This trial tests a new oral drug, CYC140, in patients with advanced cancers who have no other treatment options. It aims to see if the drug is safe and effective in stopping cancer growth or killing cancer cells.
Recruiting1 award Phase 1 & 2
More about Do-Youn Oh, MD
Clinical Trial Related2 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Do-Youn Oh, MD has experience with
- Capecitabine
- Gemcitabine
- ZW25 (Zanidatamab)
- Tucatinib
- Cisplatin
- Oxaliplatin
Breakdown of trials Do-Youn Oh, MD has run
Cancer
Stomach Cancer
Biliary Tract Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Do-Youn Oh, MD specialize in?
Do-Youn Oh, MD focuses on Cancer and Stomach Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Do-Youn Oh, MD currently recruiting for clinical trials?
Yes, Do-Youn Oh, MD is currently recruiting for 7 clinical trials in Seoul Other. If you're interested in participating, you should apply.
Are there any treatments that Do-Youn Oh, MD has studied deeply?
Yes, Do-Youn Oh, MD has studied treatments such as Capecitabine, Gemcitabine, ZW25 (Zanidatamab).
What is the best way to schedule an appointment with Do-Youn Oh, MD?
Apply for one of the trials that Do-Youn Oh, MD is conducting.
What is the office address of Do-Youn Oh, MD?
The office of Do-Youn Oh, MD is located at: Seoul National University Hospital, Seoul, Other 03080 Korea, Republic of. This is the address for their practice at the Seoul National University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.